177 related articles for article (PubMed ID: 27932250)
1. False-negative MRI breast screening in high-risk women.
Maxwell AJ; Lim YY; Hurley E; Evans DG; Howell A; Gadde S
Clin Radiol; 2017 Mar; 72(3):207-216. PubMed ID: 27932250
[TBL] [Abstract][Full Text] [Related]
2. Five-year analysis of magnetic resonance imaging as a screening tool in women at hereditary risk of breast cancer.
Kam JK; Naidu P; Rose AK; Mann GB
J Med Imaging Radiat Oncol; 2013 Aug; 57(4):400-6. PubMed ID: 23870334
[TBL] [Abstract][Full Text] [Related]
3. Supplemental Breast MR Imaging Screening of Women with Average Risk of Breast Cancer.
Kuhl CK; Strobel K; Bieling H; Leutner C; Schild HH; Schrading S
Radiology; 2017 May; 283(2):361-370. PubMed ID: 28221097
[TBL] [Abstract][Full Text] [Related]
4. Assessment of false-negative cases of breast MR imaging in women with a familial or genetic predisposition.
Obdeijn IM; Loo CE; Rijnsburger AJ; Wasser MN; Bergers E; Kok T; Klijn JG; Boetes C
Breast Cancer Res Treat; 2010 Jan; 119(2):399-407. PubMed ID: 19876732
[TBL] [Abstract][Full Text] [Related]
5. Clinical Utility of Breast MRI in the Diagnosis of Malignancy After Inconclusive or Equivocal Mammographic Diagnostic Evaluation.
Giess CS; Chikarmane SA; Sippo DA; Birdwell RL
AJR Am J Roentgenol; 2017 Jun; 208(6):1378-1385. PubMed ID: 28267372
[TBL] [Abstract][Full Text] [Related]
6. Determination of recall rates for assessment in high-risk women undergoing annual surveillance breast MRI.
Healy NA; O'Keeffe SA
Clin Radiol; 2016 Nov; 71(11):1143-7. PubMed ID: 27542654
[TBL] [Abstract][Full Text] [Related]
7. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging.
Lehman CD; Blume JD; Weatherall P; Thickman D; Hylton N; Warner E; Pisano E; Schnitt SJ; Gatsonis C; Schnall M; DeAngelis GA; Stomper P; Rosen EL; O'Loughlin M; Harms S; Bluemke DA;
Cancer; 2005 May; 103(9):1898-905. PubMed ID: 15800894
[TBL] [Abstract][Full Text] [Related]
8. Interval breast cancers: absolute and proportional incidence and blinded review in a community mammographic screening program.
Carbonaro LA; Azzarone A; Paskeh BB; Brambilla G; Brunelli S; Calori A; Caumo F; Malerba P; Menicagli L; Sconfienza LM; Vadalà G; Brambilla G; Fantini L; Ciatto S; Sardanelli F
Eur J Radiol; 2014 Feb; 83(2):e84-91. PubMed ID: 24369953
[TBL] [Abstract][Full Text] [Related]
9. MRI and mammography surveillance of women at increased risk for breast cancer: recommendations using an evidence-based approach.
Granader EJ; Dwamena B; Carlos RC
Acad Radiol; 2008 Dec; 15(12):1590-5. PubMed ID: 19000876
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
[TBL] [Abstract][Full Text] [Related]
11. How reassuring is a normal breast ultrasound in assessment of a screen-detected mammographic abnormality? A review of interval cancers after assessment that included ultrasound evaluation.
Bennett ML; Welman CJ; Celliers LM
Clin Radiol; 2011 Oct; 66(10):928-39. PubMed ID: 21718976
[TBL] [Abstract][Full Text] [Related]
12. MRI in high risk women: benefits and problems.
Cortesi L; Pecchi A; De Matteis E; Filieri E; Battista R; Canossi B; Torricelli P; Federico M
Eur J Radiol; 2012 Sep; 81 Suppl 1():S19-20. PubMed ID: 23083587
[No Abstract] [Full Text] [Related]
13. The role of magnetic resonance imaging in screening women at high risk of breast cancer.
Warner E
Top Magn Reson Imaging; 2008 Jun; 19(3):163-9. PubMed ID: 18941396
[TBL] [Abstract][Full Text] [Related]
14. Added cancer yield of breast magnetic resonance imaging screening in women with a prior history of chest radiation therapy.
Freitas V; Scaranelo A; Menezes R; Kulkarni S; Hodgson D; Crystal P
Cancer; 2013 Feb; 119(3):495-503. PubMed ID: 22952042
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of screening with annual magnetic resonance imaging and mammography: results of the initial screen from the ontario high risk breast screening program.
Chiarelli AM; Prummel MV; Muradali D; Majpruz V; Horgan M; Carroll JC; Eisen A; Meschino WS; Shumak RS; Warner E; Rabeneck L
J Clin Oncol; 2014 Jul; 32(21):2224-30. PubMed ID: 24934793
[TBL] [Abstract][Full Text] [Related]
16. First experiences in screening women at high risk for breast cancer with MR imaging.
Tilanus-Linthorst MM; Obdeijn IM; Bartels KC; de Koning HJ; Oudkerk M
Breast Cancer Res Treat; 2000 Sep; 63(1):53-60. PubMed ID: 11079159
[TBL] [Abstract][Full Text] [Related]
17. Frequency and Outcomes of Incidental Breast Lesions Detected on Abdominal MRI Over a 7-Year Period.
Prabhu V; Chhor CM; Ego-Osuala IO; Xiao JM; Hindman NM; Rosenkrantz AB
AJR Am J Roentgenol; 2017 Jan; 208(1):107-113. PubMed ID: 27809561
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of alternating mammography and magnetic resonance imaging for screening women with deleterious BRCA mutations at high risk of breast cancer.
Le-Petross HT; Whitman GJ; Atchley DP; Yuan Y; Gutierrez-Barrera A; Hortobagyi GN; Litton JK; Arun BK
Cancer; 2011 Sep; 117(17):3900-7. PubMed ID: 21365619
[TBL] [Abstract][Full Text] [Related]
19. [Breast carcinoma diagnosed in mammographic screening incidentally. Research on the radiologic signs in prior mammograms].
Marra V; Frigerio A; Di Virgilio MR; Menna S; Burke P
Radiol Med; 1999 Nov; 98(5):342-6. PubMed ID: 10780212
[TBL] [Abstract][Full Text] [Related]
20. [Early results of breast cancer screening research].
Nowicki A; Stogowska I
Ginekol Pol; 2007 Jun; 78(6):464-70. PubMed ID: 17899703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
